• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用携带凋亡基因、端粒酶特异性的溶瘤腺病毒治疗放射抗性的食管癌细胞系。

Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus.

作者信息

Zhang Xiaochun, Komaki Ritsuko, Wang Li, Fang Bingliang, Chang Joe Y

机构信息

Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

出版信息

Clin Cancer Res. 2008 May 1;14(9):2813-23. doi: 10.1158/1078-0432.CCR-07-1528.

DOI:10.1158/1078-0432.CCR-07-1528
PMID:18451249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2387204/
Abstract

PURPOSE

Radioresistance may be caused by cancer stem cells (CSC). Because CSCs require telomerase to proliferate, a telomerase-specific oncolytic adenoviral vector carrying apoptotic tumor necrosis factor-related apoptosis-inducing ligand and E1A gene (Ad/TRAIL-E1) may preferentially target CSCs.

EXPERIMENTAL DESIGN

We established two pairs of parental and radioresistant (R) esophageal carcinoma cell lines (Seg-1, Seg-1R and TE-2, TE-2R) by fractionated irradiation. Stem cell markers were measured by Western blotting and flow cytometry. Serial sorting was used to enrich stem-like side population cells. Telomerase activity, transgene expression, antitumor activity, apoptosis induction, and viral replication were determined in vitro and/or in vivo.

RESULTS

Expression of the stem cell markers beta-catenin, Oct3/4, and beta(1) integrin in Seg-1R cells was 29.4%, 27.5%, and 97.3%, respectively, compared with 4.8%, 14.9%, and 45.3% in Seg-1 cells (P < 0.05). SP levels in Seg-1R and TE-2R cells were 14.6% and 2.7%, respectively, compared with 3.4% and 0.3% in Seg-1 and TE-2 cells. Serial sorting of Seg-1R SP cells showed enrichment of the SP cells. Telomerase activities in Seg-1R, Seg-1R SP, and TE-2R cells were significantly higher than in Seg-1, Seg-1R non-SP, and TE-2 cells, respectively (P < 0.05). Seg-1R and TE-2R cells were more sensitive to Ad/TRAIL-E1 than parental cells. Increased Coxsackie-adenovirus receptor and elevated transgene expressions were found in the radioresistant cells. Ad/TRAIL-E1 resulted in significant tumor growth suppression and longer survival in Seg-1R-bearing mice (P < 0.05) with no significant toxicity.

CONCLUSION

Radioresistant cells established by fractionated irradiation display CSC-like cell properties. Ad/TRAIL-E1 preferentially targets radioresistant CSC-like cells.

摘要

目的

癌症干细胞(CSC)可能导致放射抗性。由于CSC增殖需要端粒酶,携带凋亡肿瘤坏死因子相关凋亡诱导配体和E1A基因的端粒酶特异性溶瘤腺病毒载体(Ad/TRAIL-E1)可能优先靶向CSC。

实验设计

我们通过分次照射建立了两对亲本和放射抗性(R)食管癌细胞系(Seg-1、Seg-1R和TE-2、TE-2R)。通过蛋白质免疫印迹法和流式细胞术检测干细胞标志物。采用连续分选法富集干细胞样侧群细胞。在体外和/或体内测定端粒酶活性、转基因表达、抗肿瘤活性、凋亡诱导和病毒复制。

结果

与Seg-1细胞中的4.8%、14.9%和45.3%相比,Seg-1R细胞中干细胞标志物β-连环蛋白、Oct3/4和β1整合素的表达分别为29.4%、27.5%和97.3%(P<0.05)。与Seg-1和TE-2细胞中的3.4%和0.3%相比,Seg-1R和TE-2R细胞中的SP水平分别为14.6%和2.7%。Seg-1R SP细胞的连续分选显示SP细胞得到富集。Seg-1R、Seg-1R SP和TE-2R细胞中的端粒酶活性分别显著高于Seg-1、Seg-非SP和TE-2细胞(P<0.05)。Seg-1R和TE-2R细胞比亲本细胞对Ad/TRAIL-E1更敏感。在放射抗性细胞中发现柯萨奇腺病毒受体增加和转基因表达升高。Ad/TRAIL-E1导致携带Seg-1R的小鼠肿瘤生长显著受抑制且生存期延长(P<0.05),且无明显毒性。

结论

通过分次照射建立的放射抗性细胞表现出CSC样细胞特性。Ad/TRAIL-E1优先靶向放射抗性CSC样细胞。

相似文献

1
Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus.用携带凋亡基因、端粒酶特异性的溶瘤腺病毒治疗放射抗性的食管癌细胞系。
Clin Cancer Res. 2008 May 1;14(9):2813-23. doi: 10.1158/1078-0432.CCR-07-1528.
2
Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus.通过携带肿瘤坏死因子-α相关凋亡诱导配体的溶瘤腺病毒消除裸鼠(nu/nu)体内已形成的肿瘤。
Clin Cancer Res. 2006 Sep 1;12(17):5224-30. doi: 10.1158/1078-0432.CCR-06-0244.
3
Telomerase-specific oncolytic adenovirus expressing TRAIL suppresses peritoneal dissemination of gastric cancer.表达TRAIL的端粒酶特异性溶瘤腺病毒可抑制胃癌的腹膜播散。
Gene Ther. 2017 Apr;24(4):199-207. doi: 10.1038/gt.2017.2. Epub 2017 Jan 11.
4
Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus.用携带TRAIL基因的溶瘤腺病毒靶向肺癌干细胞样细胞。
J Cell Mol Med. 2015 May;19(5):915-23. doi: 10.1111/jcmm.12397. Epub 2015 Feb 16.
5
A hypoxia- and telomerase-responsive oncolytic adenovirus expressing secretable trimeric TRAIL triggers tumour-specific apoptosis and promotes viral dispersion in TRAIL-resistant glioblastoma.缺氧和端粒酶反应性溶瘤腺病毒表达可分泌的三聚体 TRAIL 触发肿瘤特异性细胞凋亡,并促进 TRAIL 耐药性脑胶质瘤中的病毒扩散。
Sci Rep. 2018 Jan 23;8(1):1420. doi: 10.1038/s41598-018-19300-6.
6
A novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous route.一种新型衣壳修饰的溶瘤重组5型腺病毒,用于通过静脉途径进行肿瘤靶向基因治疗。
Oncotarget. 2016 Jul 26;7(30):47287-47301. doi: 10.18632/oncotarget.10075.
7
Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.携 TRAIL 基因的双调控溶瘤腺病毒靶向肝癌的肿瘤基因-病毒-治疗。
Gene Ther. 2011 Aug;18(8):765-77. doi: 10.1038/gt.2011.16. Epub 2011 Mar 17.
8
Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.溶瘤腺病毒与内皮抑素联合抑制体内小鼠模型中的人视网膜母细胞瘤。
Int J Mol Med. 2013 Feb;31(2):377-85. doi: 10.3892/ijmm.2012.1197. Epub 2012 Nov 29.
9
Treatment of patient tumor-derived colon cancer xenografts by a TRAIL gene-armed oncolytic adenovirus.携带 TRAIL 基因的溶瘤腺病毒治疗患者来源的结肠癌异种移植瘤。
Cancer Gene Ther. 2011 May;18(5):336-45. doi: 10.1038/cgt.2010.83. Epub 2010 Dec 24.
10
A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.一种靶向Wnt信号通路的新型溶瘤腺病毒通过转移、凋亡和自噬有效抑制肝癌模型中癌干细胞样细胞的生长。
Biochem Biophys Res Commun. 2017 Sep 16;491(2):469-477. doi: 10.1016/j.bbrc.2017.07.041. Epub 2017 Jul 8.

引用本文的文献

1
Aldo-keto reductase family 1 member C3 mediates radioresistance of esophageal cancer cells through suppressing MAPK and AKT signaling.醛酮还原酶家族 1 成员 C3 通过抑制 MAPK 和 AKT 信号通路介导食管癌细胞的放射抵抗。
BMC Cancer. 2024 Oct 7;24(1):1236. doi: 10.1186/s12885-024-13012-z.
2
The role of oncolytic virotherapy and viral oncogenes in the cancer stem cells: a review of virus in cancer stem cells.溶瘤病毒疗法及病毒癌基因在癌症干细胞中的作用:癌症干细胞中的病毒综述
Cancer Cell Int. 2023 Oct 25;23(1):250. doi: 10.1186/s12935-023-03099-y.
3
Current understanding of cancer stem cells: Immune evasion and targeted immunotherapy in gastrointestinal malignancies.癌症干细胞的当前认识:胃肠道恶性肿瘤中的免疫逃逸与靶向免疫治疗
Front Oncol. 2023 Feb 23;13:1114621. doi: 10.3389/fonc.2023.1114621. eCollection 2023.
4
The lipid rafts in cancer stem cell: a target to eradicate cancer.肿瘤干细胞中的脂质筏:消除癌症的新靶点。
Stem Cell Res Ther. 2022 Aug 30;13(1):432. doi: 10.1186/s13287-022-03111-8.
5
Induction and assessment of persistent radioresistance in murine leukocytes .小鼠白细胞中持续性放射抗性的诱导与评估
Biochem Biophys Rep. 2022 Jun 7;31:101296. doi: 10.1016/j.bbrep.2022.101296. eCollection 2022 Sep.
6
NRAGE Confers Radiation Resistance in 2D and 3D Cell Culture and Poor Outcome in Patients With Esophageal Squamous Cell Carcinoma.NRAGE在二维和三维细胞培养中赋予放射抗性,并与食管鳞状细胞癌患者的不良预后相关。
Front Oncol. 2022 Apr 1;12:831506. doi: 10.3389/fonc.2022.831506. eCollection 2022.
7
HSP90 promotes radioresistance of cervical cancer cells via reducing FBXO6-mediated CD147 polyubiquitination.HSP90 通过减少 FBXO6 介导的 CD147 多泛素化促进宫颈癌的放射抵抗性。
Cancer Sci. 2022 Apr;113(4):1463-1474. doi: 10.1111/cas.15269. Epub 2022 Feb 22.
8
Efficacy and safety of a third-generation oncolytic herpes virus G47Δ in models of human esophageal carcinoma.第三代溶瘤性疱疹病毒G47Δ在人食管癌模型中的疗效与安全性
Mol Ther Oncolytics. 2021 Oct 30;23:402-411. doi: 10.1016/j.omto.2021.10.012. eCollection 2021 Dec 17.
9
Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment.化疗和放疗耐药的分子机制及其对癌症治疗的潜在影响。
MedComm (2020). 2021 Jun 10;2(3):315-340. doi: 10.1002/mco2.55. eCollection 2021 Sep.
10
Therapeutic Strategies Against Cancer Stem Cells in Esophageal Carcinomas.食管癌中针对癌症干细胞的治疗策略
Front Oncol. 2021 Feb 16;10:598957. doi: 10.3389/fonc.2020.598957. eCollection 2020.

本文引用的文献

1
The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.CD24(- /低)/ CD44 +乳腺癌起始细胞对辐射的反应。
J Natl Cancer Inst. 2006 Dec 20;98(24):1777-85. doi: 10.1093/jnci/djj495.
2
Cancer stem cells and radiotherapy: new insights into tumor radioresistance.癌症干细胞与放射治疗:肿瘤放射抗性的新见解
J Natl Cancer Inst. 2006 Dec 20;98(24):1755-7. doi: 10.1093/jnci/djj505.
3
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.胶质瘤干细胞通过优先激活DNA损伤反应来促进放射抗性。
Nature. 2006 Dec 7;444(7120):756-60. doi: 10.1038/nature05236. Epub 2006 Oct 18.
4
SP analysis may be used to identify cancer stem cell populations.免疫组织化学分析可用于识别癌症干细胞群体。
Exp Cell Res. 2006 Nov 15;312(19):3701-10. doi: 10.1016/j.yexcr.2006.08.030. Epub 2006 Sep 9.
5
Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.癌症干细胞——现状与未来方向展望:美国癌症研究协会癌症干细胞研讨会
Cancer Res. 2006 Oct 1;66(19):9339-44. doi: 10.1158/0008-5472.CAN-06-3126. Epub 2006 Sep 21.
6
Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus.通过携带肿瘤坏死因子-α相关凋亡诱导配体的溶瘤腺病毒消除裸鼠(nu/nu)体内已形成的肿瘤。
Clin Cancer Res. 2006 Sep 1;12(17):5224-30. doi: 10.1158/1078-0432.CCR-06-0244.
7
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.通过特定因子从小鼠胚胎和成体成纤维细胞培养物中诱导多能干细胞。
Cell. 2006 Aug 25;126(4):663-76. doi: 10.1016/j.cell.2006.07.024. Epub 2006 Aug 10.
8
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness.卵巢癌侧群细胞定义了具有干细胞样特征和苗勒管抑制物质反应性的细胞。
Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11154-9. doi: 10.1073/pnas.0603672103. Epub 2006 Jul 18.
9
Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus.一种条件性复制腺病毒诱导恶性胶质瘤细胞的自噬性细胞死亡
J Natl Cancer Inst. 2006 May 3;98(9):625-36. doi: 10.1093/jnci/djj161.
10
Telomeres and telomerase in cancer stem cells.癌症干细胞中的端粒与端粒酶
Eur J Cancer. 2006 Jun;42(9):1197-203. doi: 10.1016/j.ejca.2006.01.040. Epub 2006 Apr 27.